User profiles for A. Moes

Arthur D. Moes

Erasmus MC
Verified email at erasmusmc.nl
Cited by 342

Gastroretentive dosage forms.

AJ Moës - Critical reviews in therapeutic drug carrier systems, 1993 - europepmc.org
This article begins with a review of gastric emptying, small intestine transit, and colonic transit
of drug delivery systems with special attention paid to the different physiological processes …

[HTML][HTML] Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism

S Gupta, SE Ellis, FN Ashar, A Moes, JS Bader… - Nature …, 2014 - nature.com
Recent studies of genomic variation associated with autism have suggested the existence
of extreme heterogeneity. Large-scale transcriptomics should complement these results to …

The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation

AD Moes, N van der Lubbe, R Zietse, J Loffing… - … -European Journal of …, 2014 - Springer
SLC12A3 encodes the thiazide-sensitive sodium chloride cotransporter (NCC), which is
primarily expressed in the kidney, but also in intestine and bone. In the kidney, NCC is located …

Association of mitochondrial DNA levels with frailty and all-cause mortality

FN Ashar, A Moes, AZ Moore, ML Grove… - Journal of molecular …, 2015 - Springer
Mitochondrial function is altered with age and variants in mitochondrial DNA (mtDNA)
modulate risk for several age-related disease states. However, the association of mtDNA copy …

Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy

J Timmermans, AJ Moës - Journal of pharmaceutical sciences, 1994 - Wiley Online Library
Optimized floating (F) and non‐floating (NF) hydrophilic matrix capsules have been
characterized in vitro with regard to their buoyancy or non—buoyancy capabilities and their …

How well do floating dosage forms float?

J Timmermans, AJ Moës - International journal of pharmaceutics, 1990 - Elsevier
Peroral floating dosage forms have up to now been used and prescribed without having
achieved any determination of their real floating capabilities versus time. Using a novel in vitro …

Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets

J Hamdani, AJ Moës, K Amighi - International journal of pharmaceutics, 2003 - Elsevier
Physical and thermal properties of Compritol ® and Precirol ® as potential lipophilic binders
in melt pelletisation process for the preparation of sustained-release matrix pellets were …

Association of mitochondrial DNA copy number with cardiovascular disease

…, Y Zhang, RJ Longchamps, J Lane, A Moes… - JAMA …, 2017 - jamanetwork.com
Importance Mitochondrial dysfunction is a core component of the aging process and may
play a key role in atherosclerotic cardiovascular disease. Mitochondrial DNA copy number (…

Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly (DL-lactide-co-glycolide) microspheres

P Sansdrap, AJ Moës - International journal of pharmaceutics, 1993 - Elsevier
Empty or nifedipine-loaded biodegradable poly(dl-lactide-co-glycolide) microspheres were
prepared by the solvent evaporation method. Spherical microparticles of different size …

Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit

HM Ingani, J Timmermans, AJ Moës - International journal of pharmaceutics, 1987 - Elsevier
Previous published works have shown that hydrodynamically balanced systems (HBS) — ie
sustained release oral dosage forms with a specific gravity lower than 1 and remaining …